Inhibition of high-mobility group box 1 as therapeutic option in autoimmune disease
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibition of high-mobility group box 1 as therapeutic option in autoimmune disease
Authors
Keywords
-
Journal
CURRENT OPINION IN RHEUMATOLOGY
Volume 25, Issue 2, Pages 254-259
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2012-12-29
DOI
10.1097/bor.0b013e32835cee2d
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- High Mobility Group Box 1 Protein Binding to Lipopolysaccharide Facilitates Transfer of Lipopolysaccharide to CD14 and Enhances Lipopolysaccharide-Mediated TNF- Production in Human Monocytes
- (2014) J. H. Youn et al. JOURNAL OF IMMUNOLOGY
- High Mobility Group Box 1 Promotes Small Intestinal Damage Induced by Nonsteroidal Anti-Inflammatory Drugs through Toll-Like Receptor 4
- (2012) Yuji Nadatani et al. AMERICAN JOURNAL OF PATHOLOGY
- HMGB1 in vascular diseases: Its role in vascular inflammation and atherosclerosis
- (2012) A.W.S. de Souza et al. AUTOIMMUNITY REVIEWS
- HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4
- (2012) Milena Schiraldi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release
- (2012) Emilie Venereau et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The persistent release of HMGB1 contributes to tactile hyperalgesia in a rodent model of neuropathic pain
- (2012) Polina Feldman et al. Journal of Neuroinflammation
- Role of high mobility group box chromosomal protein 1 in ischemia-reperfusion injury in the rat small intestine
- (2012) Masayuki Kojima et al. JOURNAL OF SURGICAL RESEARCH
- Unknown
- (2012) Hulda Hreggvidsdottir et al. MOLECULAR MEDICINE
- Unknown
- (2012) Huan Yang et al. MOLECULAR MEDICINE
- Intranasal Delivery of HMGB1 siRNA Confers Target Gene Knockdown and Robust Neuroprotection in the Postischemic Brain
- (2012) Il-Doo Kim et al. MOLECULAR THERAPY
- Evaluation of 3-(3-chloro-phenyl)-5-(4-pyridyl)-4,5-dihydroisoxazole as a Novel Anti-Inflammatory Drug Candidate
- (2012) Amanda Roberta Revoredo Vicentino et al. PLoS One
- Increased serum levels of high-mobility group box 1 (HMGB1) in primary Sjögren's syndrome
- (2012) G Dupire et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
- Systemic Involvement of High-Mobility Group Box 1 Protein and Therapeutic Effect of Anti–High-Mobility Group Box 1 Protein Antibody in a Rat Model of Crush Injury
- (2012) Junya Shimazaki et al. SHOCK
- Prevention of High-Mobility Group Box 1-Mediated Early Loss of Transplanted Mouse Islets in the Liver by Antithrombin III
- (2012) Daibo Kojima et al. TRANSPLANTATION
- Urine levels of HMGB1 in Systemic Lupus Erythematosus patients with and without renal manifestations
- (2012) Deena A Abdulahad et al. ARTHRITIS RESEARCH & THERAPY
- Glucan phosphate attenuates myocardial HMGB1 translocation in severe sepsis through inhibiting NF-κB activation
- (2011) Tuanzhu Ha et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Size-Dependent Attenuation of TLR9 Signaling by Gold Nanoparticles in Macrophages
- (2011) C.-Y. Tsai et al. JOURNAL OF IMMUNOLOGY
- High-mobility group box 1 represents a potential marker of disease activity and novel therapeutic target in systemic lupus erythematosus
- (2011) V. Urbonaviciute et al. JOURNAL OF INTERNAL MEDICINE
- Unknown
- (2011) Hanna Schierbeck et al. MOLECULAR MEDICINE
- Anti-HMGB1 Neutralization Antibody Improves Pain-Related Behavior Induced by Application of Autologous Nucleus Pulposus Onto Nerve Roots in Rats
- (2011) Ken-ichi Otoshi et al. SPINE
- Anti-high Mobility Group Box-1 Monoclonal Antibody Protects the Blood–Brain Barrier From Ischemia-Induced Disruption in Rats
- (2011) Jiyong Zhang et al. STROKE
- High mobility group box protein 1 in complex with lipopolysaccharide or IL-1 promotes an increased inflammatory phenotype in synovial fibroblasts
- (2011) Heidi Wähämaa et al. ARTHRITIS RESEARCH & THERAPY
- High mobility group box 1 (HMGB1) and anti-HMGB1 antibodies and their relation to disease characteristics in systemic lupus erythematosus
- (2011) Deena A Abdulahad et al. ARTHRITIS RESEARCH & THERAPY
- TLR4 Mediates Early Graft Failure After Intraportal Islet Transplantation
- (2010) Q. Gao et al. AMERICAN JOURNAL OF TRANSPLANTATION
- High-Mobility Group Box Protein 1 Neutralization Reduces Development of Diet-Induced Atherosclerosis in Apolipoprotein E–Deficient Mice
- (2010) Peter Kanellakis et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Protective targeting of high mobility group box chromosomal protein 1 in a spontaneous arthritis model
- (2010) Therese Östberg et al. ARTHRITIS AND RHEUMATISM
- Metformin inhibits HMGB1 release in LPS-treated RAW 264.7 cells and increases survival rate of endotoxaemic mice
- (2010) Konstantin Tsoyi et al. BRITISH JOURNAL OF PHARMACOLOGY
- HMGB1 Contributes to Kidney Ischemia Reperfusion Injury
- (2010) H. Wu et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Unknown
- (2010) Hanna Schierbeck et al. MOLECULAR MEDICINE
- Unknown
- (2010) Daniel Antoine et al. MOLECULAR MEDICINE
- Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures
- (2010) Mattia Maroso et al. NATURE MEDICINE
- Induction of high mobility group box-1 in dorsal root ganglion contributes to pain hypersensitivity after peripheral nerve injury
- (2010) Masayuki Shibasaki et al. PAIN
- A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release
- (2010) H. Yang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation
- (2009) Hulda Sigridur Hreggvidsdottir et al. JOURNAL OF LEUKOCYTE BIOLOGY
- ROLE OF TOLL-LIKE RECEPTORS 2 AND 4, AND THE RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS IN HIGH-MOBILITY GROUP BOX 1-INDUCED INFLAMMATION IN VIVO
- (2009) Marieke A.D. van Zoelen et al. SHOCK
- Induction of Immunological Tolerance by Apoptotic Cells Requires Caspase-Dependent Oxidation of High-Mobility Group Box-1 Protein
- (2008) Hirotaka Kazama et al. IMMUNITY
- Induction of inflammatory and immune responses by HMGB1–nucleosome complexes: implications for the pathogenesis of SLE
- (2008) Vilma Urbonaviciute et al. JOURNAL OF EXPERIMENTAL MEDICINE
- High-Mobility Group Box 1 Protein in Human and Murine Skin: Involvement in Wound Healing
- (2008) Stefania Straino et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Oxaliplatin retains HMGB1 intranuclearly and ameliorates collagen type II-induced arthritis
- (2008) Therese Ostberg et al. ARTHRITIS RESEARCH & THERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now